Literature DB >> 20559041

HIV-associated neurocognitive disorders: is there a hidden epidemic?

Justin C McArthur, Bruce J Brew.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20559041     DOI： 10.1097/QAD.0b013e3283391d56

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  55 in total

1.  Cognitive disorders in HIV-infected and AIDS patients in Guangxi, China.

Authors:  Tingting Zhao; Bo Wei; Jianxiong Long; Xianyan Tang; Mengxiao Zhou; Chao Dang
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women.

Authors:  Yamil Gerena; Richard L Skolasky; Joyce M Velez; Dianedis Toro-Nieves; Raul Mayo; Avindra Nath; Valerie Wojna
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

Review 3.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

4.  A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier.

Authors:  Alicia McFarren; Lillie Lopez; Dionna W Williams; Mike Veenstra; Ruth A Bryan; Aliza Goldsmith; Alfred Morgenstern; Frank Bruchertseifer; Susan Zolla-Pazner; Miroslaw K Gorny; Eliseo A Eugenin; Joan W Berman; Ekaterina Dadachova
Journal:  AIDS       Date:  2016-02-20       Impact factor: 4.177

5.  HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorder.

Authors:  Pichili Vijaya Bhaskar Reddy; Nimisha Gandhi; Thangavel Samikkannu; Zainulabedin Saiyed; Marisela Agudelo; Adriana Yndart; Pradnya Khatavkar; Madhavan P N Nair
Journal:  Neurochem Int       Date:  2011-07-03       Impact factor: 3.921

Review 6.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

7.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

8.  Impact of antiretroviral therapy on HIV-related brain injury.

Authors:  Richard W Price
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

Review 9.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 10.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.